FDA Drug Application (204078) for BLOXIVERZ by ECLAT PHARMS LLC

Back to FDA Applications sponsored by ECLAT PHARMS LLC

Application Number204078
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage5MG/10ML (0.5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameBLOXIVERZ
Active IngredientNEOSTIGMINE METHYLSULFATE



Back to FDA Applications sponsored by ECLAT PHARMS LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.